Outcomes from an Early Adopters Home Hospital Accelerator for Acute Care at Home.

Autor: Desai M; Ariadne Labs, Boston, MA, USA., Findeisen S; Ariadne Labs, Boston, MA, USA., Blitzer S; Ariadne Labs, Boston, MA, USA., Tardif-Douglin M; CaroNova, Cary, NC, USA.; North Carolina Healthcare Association, Cary, NC, USA., Miller I; Ariadne Labs, Boston, MA, USA., Leff B; Center for Transformative Geriatric Research, Division of Geriatric Medicine, Johns Hopkins University School of Medicine, Baltimore, USA., Edmondson L; CaroNova, Cary, NC, USA.; North Carolina Healthcare Association, Cary, NC, USA., Hernandez C; Research and Innovation Management, Hospital Clinic, Barcelona, Spain.; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital; Boston, Boston, MA, USA., Levine DM; Ariadne Labs, Boston, MA, USA. dmlevine@bwh.harvard.edu.; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital; Boston, Boston, MA, USA. dmlevine@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. dmlevine@bwh.harvard.edu.
Jazyk: angličtina
Zdroj: Journal of general internal medicine [J Gen Intern Med] 2024 Oct; Vol. 39 (13), pp. 2505-2514. Date of Electronic Publication: 2024 Jun 27.
DOI: 10.1007/s11606-024-08869-6
Abstrakt: Background: Following the Centers for Medicare and Medicaid Services' approval of the Acute Hospital Care at Home waiver, an increasing number of health care organizations launched Home Hospital (HH) programs in the USA. Ongoing barriers include access to HH expertise and a standard, comprehensive set of implementation tools. We created the HH Early Adopters Accelerator to bring together a network of health care organizations to develop tools ("knowledge products") necessary for HH implementation.
Objective: To demonstrate the feasibility of the Accelerator approach for generating and implementing relevant, high-quality knowledge products.
Design: Mixed methods evaluation of the Accelerator. Surveys and qualitative interviews of Accelerator participants were conducted. Surveys elicited feedback on the knowledge products, including time spent on development, perceived utility and quality, and implementation success. The qualitative interviews gathered more in-depth information on topics covered in the surveys.
Participants: Eighteen healthcare organizations and 105 individuals participated in the Accelerator.
Key Results: The Accelerator reached its goal and developed 20 knowledge products in 32 working weeks (more efficient than expected). Participants agreed that the knowledge products were useful (developers: 98.1%; stakeholders: 93.8%), of high quality (developers: 96.8%), and would improve patient care if implemented in their HH program (developers: 91.7%; stakeholders: 91.2%). Two thirds (66.7%) of the participating organizations who had implemented knowledge products at 3 months continued utilizing knowledge products in their HH program at 1 year. Agreement that knowledge products improve patient care persisted (92% strongly agreed or agreed) at 1 year. Several programs created new tools, policies, and workflows as a result of implementing the knowledge products.
Conclusions: The Accelerator created high-quality, comprehensive knowledge products that healthcare organizations found useful for safe HH implementation 1 year later. The Accelerator approach can feasibly help healthcare organizations safely bridge the gap between innovation and standard practice.
(© 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.)
Databáze: MEDLINE